H yperventilation has been an integral part of the management of neurosurgical patients for the past 50 years. It has been so emblematic that a blindfolded individual could easily identify a neurosurgical operating room by the sound of the hard working ventilator. However, the routine use of hyperventilation has been re-evaluated with the emergence of evidence that it could be harmful.The first description of the benefits of hyperventilation in neuroanesthesia was published in 1957. 1 In the report, Furness reviewed the outcomes of 72 patients receiving "adequate ventilation" with a fixed ventilatory frequency of 20 breaths·min -1 during craniotomy. Although there was no formal assessment of the operating conditions and no measurement of arterial carbon dioxide tension (PaCO 2 ), "gradually the neurosurgeons were completely convinced" that hyperventilation produced better conditions compared with their previous experience using spontaneous ventilation. The report neglected to distinguish among the roles of hypocapnia, mechanical ventilation vs spontaneous breathing, and the contribution of muscle relaxation. 2,3 These latter were the subject of much debate and some research over the next decade.
Neurophysiology of hyperventilationHyperventilation increases cerebral perivascular pH, resulting in cerebral arterial vasoconstriction and the decrease in cerebral blood flow (CBF) and cerebral blood volume (CBV). The CBV response to hyperventilation is blunted when compared to that of CBF. In general, for every mmHg decrease in PaCO 2 , there is a 1% decrease in CBV and a 2-3% decrease in CBF. 4 It is the reduction in CBV associated with hyperventilation that explains the decrease in intracranial pressure (ICP). 4,5 This response gradually normalizes over 12-24 hr. If hyperventilation is extended beyond this period, a restoration to normal PaCO 2 values may result in hyperemia and elevated ICP.
Hyperventilation for neurocritical careGiven its favourable effect on ICP in experimental circumstances, aggressive hyperventilation was seen as a cheap, easy, and reversible treatment for patients with intracranial hypertension. Other perceived benefits included a redistribution of CBF to ischemic regions of the brain and the reversal of acidosis in the brain and cerebrospinal fluid (CSF). 4 Despite these claims, good outcome studies demonstrating a clear benefit of hyperventilation in the operating room or the neurocritical care unit were lacking. Indeed, studies using ICP as a surrogate endpoint often reported variable responses after hyperventilation in critically ill patients. 6,7 We believe this may be attributed to the heterogeneity of the human diseases as opposed to the controlled environment in the laboratory.The enthusiasm for hyperventilation therapy came to a sudden halt when almost 17 years ago Muizelaar et al. 8 reported the deleterious effect of prolonged hyperventilation in brain injured patients. A total of 113 patients with severe head injury were randomized to receive hyperventilation (PaCO 2 , 24-28 mmHg), h...